by nms-sync | Sep 21, 2023 | News
Nerviano Medical Sciences (NMS), una Biotech focalizzata sulla ricerca e sviluppo di farmaci Oncologici innovativi, partecipa alla Settimana Europea delle Biotecnologie (European Biotech Week – EBW), giunta quest’anno alla sua XI edizione.
...
by nms-sync | Sep 20, 2023 | News
Nerviano, September 20, 2023 – Nerviano Medical Sciences S.r.l. (NMS), a member of NMS Group S.p.A. and a clinical stage biotech, discovering and developing innovative therapies for the treatment of cancer, today announces the publication of preclinical data on...
by nms-sync | Sep 19, 2023 | News
September 19th, 2023
2023 | News
NERVIANO, Italy—September 19th, 2023—SIMIS Srl (SIMIS), a NMS Group company, is pleased to announce the appointment of Laurent Contaut as the new Chief Executive Officer (CEO) of the organization, effective...
by nms-sync | Sep 11, 2023 | News
Nerviano Italy, 11 September 2023 – Nerviano Medical Sciences Srl (NMS Srl), a member of NMS Group and a clinical stage company discovering and developing innovative therapies for the treatment of cancer, today announced that Alberto Ocana PhD, has joined the Global...
by nms-sync | Aug 1, 2023 | News
NERVIANO, IT and BOSTON, Mass., August 1, 2023 – Nerviano Medical Sciences S.r.l., a part of NMS Group S.p.A. (NMS Group), focused on the discovery and early development of oncology drugs and the largest oncological R&D company in Italy, announced today the...
by nms-sync | Jun 22, 2023 | News
Nerviano 22 June 2023_Nerviano Medical Sciences Srl (NMS), a member of NMS Group and a clinical stage company discovering and developing innovative therapies for the treatment of cancer, is delighted to announce the FDA Clearance of Investigational New Drug (IND)...
Recent Comments